The Leu72Met polymorphism of the ghrelin gene is associated with a decreased risk for type 2 diabetes

Clinica Chimica Acta

Volumn 399, Issue 1-2, 2009, Pages 112-116

  Berthold, Heiner K ^a   Giannakidou, Eleni ^b   Krone, Wilhelm ^b   Mantzoros, Christos S ^c   Gouni Berthold, Ioanna ^b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Atherosclerotic disease; Genetic association; Ghrelin; Leu72Met; Polymorphism; Type 2 diabetes

Indexed keywords

GHRELIN; LEUCINE; METHIONINE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CAUCASIAN; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK REDUCTION;

AGED; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GHRELIN; HUMANS; LEUCINE; MALE; METHIONINE; MIDDLE AGED; POLYMORPHISM, GENETIC; REFERENCE VALUES;

EID: 57049117340     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.09.022     Document Type: Article

References (40)

1. van der Lely A.J., Tschop M., Heiman M.L., and Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25 (2004) 426-457
2. Li W.G., Gavrila D., Liu X., et al. Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation 109 (2004) 2221-2226
3. Okumura H., Nagaya N., Enomoto M., Nakagawa E., Oya H., and Kangawa K. Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. J Cardiovasc Pharmacol 39 (2002) 779-783
4. Tesauro M., Schinzari F., Iantorno M., et al. Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation 112 (2005) 2986-2992
5. Kojima M., and Kangawa K. Ghrelin: structure and function. Physiol Rev 85 (2005) 495-522
6. Katugampola S.D., Pallikaros Z., and Davenport A.P. [125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis. Br J Pharmacol 134 (2001) 143-149
7. Purnell J.Q., Weigle D.S., Breen P., and Cummings D.E. Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans. J Clin Endocrinol Metab 88 (2003) 5747-5752
8. Poykko S.M., Kellokoski E., Horkko S., Kauma H., Kesaniemi Y.A., and Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 52 (2003) 2546-2553
9. Anderwald C., Brabant G., Bernroider E., et al. Insulin-dependent modulation of plasma ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients. Diabetes 52 (2003) 1792-1798
10. Natalucci G., Riedl S., Gleiss A., Zidek T., and Frisch H. Spontaneous 24-h ghrelin secretion pattern in fasting subjects: maintenance of a meal-related pattern. Eur J Endocrinol 152 (2005) 845-850
11. Date Y., Nakazato M., Hashiguchi S., et al. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes 51 (2002) 124-129
12. Broglio F., Arvat E., Benso A., et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 86 (2001) 5083-5086
13. Tschop M., Weyer C., Tataranni P.A., Devanarayan V., Ravussin E., and Heiman M.L. Circulating ghrelin levels are decreased in human obesity. Diabetes 50 (2001) 707-709
14. Poykko S.M., Kellokoski E., Ukkola O., et al. Plasma ghrelin concentrations are positively associated with carotid artery atherosclerosis in males. J Intern Med 260 (2006) 43-52
15. Mager U., Lindi V., Lindstrom J., et al. Association of the Leu72Met polymorphism of the ghrelin gene with the risk of Type 2 diabetes in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study. Diabet Med 23 (2006) 685-689
16. Choi H.J., Cho Y.M., Moon M.K., et al. Polymorphisms in the ghrelin gene are associated with serum high-density lipoprotein cholesterol level and not with type 2 diabetes mellitus in Koreans. J Clin Endocrinol Metab 91 (2006) 4657-4663
17. Kim S.Y., Jo D.S., Hwang P.H., et al. Preproghrelin Leu72Met polymorphism is not associated with type 2 diabetes mellitus. Metabolism 55 (2006) 366-370
18. Larsen L.H., Gjesing A.P., Sorensen T.I., et al. Mutation analysis of the preproghrelin gene: no association with obesity and type 2 diabetes. Clin Biochem 38 (2005) 420-424
19. Ukkola O., and Kesaniemi Y.A. Preproghrelin Leu72Met polymorphism in patients with type 2 diabetes mellitus. J Intern Med 254 (2003) 391-394
20. Kuzuya M., Ando F., Iguchi A., and Shimokata H. Preproghrelin Leu72Met variant contributes to overweight in middle-aged men of a Japanese large cohort. Int J Obes (Lond) 30 (2006) 1609-1614
21. Ukkola O., Ravussin E., Jacobson P., et al. Mutations in the preproghrelin/ghrelin gene associated with obesity in humans. J Clin Endocrinol Metab 86 (2001) 3996-3999
22. Tang N.P., Wang L.S., Yang L., et al. Preproghrelin Leu72Met polymorphism in Chinese subjects with coronary artery disease and controls. Clin Chim Acta 387 (2008) 42-47
23. Gouni-Berthold I., Giannakidou E., Muller-Wieland D., et al. Association between the PPARalpha L162V polymorphism, plasma lipoprotein levels, and atherosclerotic disease in patients with diabetes mellitus type 2 and in nondiabetic controls. Am Heart J 147 (2004) 1117-1124
24. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus ADA. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
25. Chan J.L., Bullen J., Lee J.H., Yiannakouris N., and Mantzoros C.S. Ghrelin levels are not regulated by recombinant leptin administration and/or three days of fasting in healthy subjects. J Clin Endocrinol Metab 89 (2004) 335-343
26. Steinle N.I., Pollin T.I., O'Connell J.R., Mitchell B.D., and Shuldiner A.R. Variants in the ghrelin gene are associated with metabolic syndrome in the Old Order Amish. J Clin Endocrinol Metab 90 (2005) 6672-6677
27. Zavarella S., Petrone A., Zampetti S., et al. A new variation in the promoter region, the -604 C>T, and the Leu72Met polymorphism of the ghrelin gene are associated with protection to insulin resistance. Int J Obes (Lond) 32 (2008) 663-668
28. Robitaille J., Perusse L., Bouchard C., and Vohl M.C. Genes, fat intake, and cardiovascular disease risk factors in the Quebec Family Study. Obesity (Silver Spring) 15 (2007) 2336-2347
29. Monteleone P., Tortorella A., Castaldo E., Di F.C., and Maj M. The Leu72Met polymorphism of the ghrelin gene is significantly associated with binge eating disorder. Psychiatr Genet 17 (2007) 13-16
30. Bing C., Ambye L., Fenger M., et al. Large-scale studies of the Leu72Met polymorphism of the ghrelin gene in relation to the metabolic syndrome and associated quantitative traits. Diabet Med 22 (2005) 1157-1160
31. Ando T., Komaki G., Naruo T., et al. Possible role of preproghrelin gene polymorphisms in susceptibility to bulimia nervosa. Am J Med Genet B Neuropsychiatr Genet 141B (2006) 929-934
32. Zou C.C., Huang K., Liang L., and Zhao Z.Y. Polymorphisms of the ghrelin/obestatin gene and ghrelin levels in Chinese children with short stature. Clin Endocrinol (Oxf) 69 (2008) 99-104
33. Vivenza D., Rapa A., Castellino N., et al. Ghrelin gene polymorphisms and ghrelin, insulin, IGF-I, leptin and anthropometric data in children and adolescents. Eur J Endocrinol 151 (2004) 127-133
34. Ando T., Ichimaru Y., Konjiki F., Shoji M., and Komaki G. Variations in the preproghrelin gene correlate with higher body mass index, fat mass, and body dissatisfaction in young Japanese women. Am J Clin Nutr 86 (2007) 25-32
35. Ukkola O., Ravussin E., Jacobson P., et al. Role of ghrelin polymorphisms in obesity based on three different studies. Obes Res 10 (2002) 782-791
36. Anderwald-Stadler M., Krebs M., Promintzer M., et al. Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans. Am J Physiol Endocrinol Metab 293 (2007) E1393-E1398
37. Cummings D.E., Purnell J.Q., Frayo R.S., Schmidova K., Wisse B.E., and Weigle D.S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50 (2001) 1714-1719
38. Korbonits M., Gueorguiev M., O'Grady E., et al. A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children. J Clin Endocrinol Metab 87 (2002) 4005-4008
39. Miraglia del G.E., Santoro N., Cirillo G., et al. Molecular screening of the ghrelin gene in Italian obese children: the Leu72Met variant is associated with an earlier onset of obesity. Int J Obes Relat Metab Disord 28 (2004) 447-450
40. Poykko S.M., Kellokoski E., Horkko S., Kauma H., Kesaniemi Y.A., and Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 52 (2003) 2546-2553